National Bank of Canada
BBH icon

National Bank of Canada’s VanEck Biotech ETF BBH Stock Holding History

National Bank of Canada’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25
Closed -$4.14K – 2896
2025
Q3 		$4.14K Hold
25
– – ﹤0.01% 2487
2025
Q2 		$3.83K Hold
25
– – ﹤0.01% 2543
2025
Q1 		$3.93K Hold
25
– – ﹤0.01% 2413
2024
Q4 		$3.92K Sell
25
-50
-67% -$8.41K ﹤0.01% 2480
2024
Q3 		$13.3K Hold
75
– – ﹤0.01% 2018
2024
Q2 		$12.6K Hold
75
– – ﹤0.01% 2079
2024
Q1 		$12.3K Sell
75
-2,205
-97% -$365K ﹤0.01% 2123
2023
Q4 		$385K Buy
2,280
+2,205
+2,940% +$339K ﹤0.01% 1310
2023
Q3 		$11.6K Hold
75
– – ﹤0.01% 2165
2023
Q2 		$11.7K Hold
75
– – ﹤0.01% 2138
2023
Q1 		$12.1K Hold
75
– – ﹤0.01% 2084
2022
Q4 		$12K Hold
75
– – ﹤0.01% 2137
2022
Q3 		$11K Hold
75
– – ﹤0.01% 2148
2022
Q2 		$11K Hold
75
– – ﹤0.01% 2227
2022
Q1 		$12K Hold
75
– – ﹤0.01% 2313
2021
Q4 		$14K Buy
+75
New +$14.5K ﹤0.01% 2241

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

National Bank of Canada's BBH Position: Q4 2025 in Review

National Bank of Canada sold out of VanEck Biotech ETF (BBH) in Q4 2025, closing a stake of 25 shares — an estimated $4.14K sold.

National Bank of Canada first reported a position in BBH in Q4 2021 and held it in 16 quarters. The position peaked at $385K in Q4 2023. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

  • National Bank of Canada reported no remaining VanEck Biotech ETF position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 25 VanEck Biotech ETF shares in Q4 2025, an estimated $4.14K.
  • National Bank of Canada first reported a position in VanEck Biotech ETF in Q4 2021 and held it in 16 quarters.
  • National Bank of Canada's VanEck Biotech ETF position peaked at $385K in Q4 2023.
  • 111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.